The Online Investor

Slideshow 25 Top Lowest PE Ratios in the S&P 500

By The Online Investor Staff, updated Sat., Jul. 2, 12:23 PM

#25. Organon & Co (NYSE:OGN) PE Ratio: 6.45

Organon & Co. is a health care company, focused on improving the health of women throughout their lives. Co. develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Co. has a portfolio of medicines and products across a range of therapeutic areas. Co. sells these products through various channels including drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Co. operates manufacturing facilities located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the U.K.

OGN SEC Filing Email Alerts Service

Open the OGN Page at The Online Investor »

Company Name: 
Organon & Co
Drugs & Pharmaceuticals
Number of ETFs Holding OGN: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the OGN Page at The Online Investor (in a new window) »

List of Low PE Ratio Stocks in this Slideshow: Company Ticker PE Ratio Berkshire Hathaway Inc BRK.B 0.11 eBay Inc. EBAY 2.09 EMBC 3.58 Bio-Rad Laboratories Inc BIO 3.98 PVH Corp PVH 4.29 Nucor Corp. NUE 4.56 DuPont de Nemours Inc DD 4.60 Citigroup Inc C 4.62 DISH Network Corp DISH 4.85 Hewlett Packard Enterprise Co HPE 5.02 Goldman Sachs Group Inc GS 5.03 Lennar Corp LEN 5.23 Cooper Companies, Inc. (The) COO 5.38 Invesco Ltd IVZ 5.49 Marathon Petroleum Corp. MPC 5.54 Whirlpool Corp WHR 5.56 Bath & Body Works Inc BBWI 5.71 Lumen Technologies Inc LUMN 5.83 HP Inc HPQ 5.98 Willis Towers Watson Public Ltd Co WTW 6.08 Horton (DR) Inc DHI 6.14 Dow Inc DOW 6.17 Lincoln National Corp. LNC 6.41 Paramount Global PARA 6.43 Organon & Co OGN 6.45
Quotes delayed 20 minutes

Email EnvelopeFree OGN Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.14 out of 4)
25th percentile
(ranked lower than approx. 75% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Top 25 Lowest P/E Ratios of the S&P 500 Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.